全文获取类型
收费全文 | 6309篇 |
免费 | 517篇 |
国内免费 | 5篇 |
专业分类
耳鼻咽喉 | 45篇 |
儿科学 | 277篇 |
妇产科学 | 192篇 |
基础医学 | 825篇 |
口腔科学 | 108篇 |
临床医学 | 659篇 |
内科学 | 1474篇 |
皮肤病学 | 62篇 |
神经病学 | 509篇 |
特种医学 | 301篇 |
外国民族医学 | 1篇 |
外科学 | 939篇 |
综合类 | 80篇 |
一般理论 | 1篇 |
预防医学 | 459篇 |
眼科学 | 102篇 |
药学 | 309篇 |
中国医学 | 8篇 |
肿瘤学 | 480篇 |
出版年
2021年 | 52篇 |
2019年 | 65篇 |
2018年 | 94篇 |
2017年 | 72篇 |
2016年 | 84篇 |
2015年 | 118篇 |
2014年 | 124篇 |
2013年 | 189篇 |
2012年 | 277篇 |
2011年 | 267篇 |
2010年 | 178篇 |
2009年 | 158篇 |
2008年 | 255篇 |
2007年 | 238篇 |
2006年 | 259篇 |
2005年 | 267篇 |
2004年 | 245篇 |
2003年 | 205篇 |
2002年 | 229篇 |
2001年 | 219篇 |
2000年 | 180篇 |
1999年 | 172篇 |
1998年 | 81篇 |
1997年 | 72篇 |
1996年 | 74篇 |
1995年 | 93篇 |
1994年 | 78篇 |
1993年 | 75篇 |
1992年 | 174篇 |
1991年 | 170篇 |
1990年 | 145篇 |
1989年 | 158篇 |
1988年 | 141篇 |
1987年 | 159篇 |
1986年 | 126篇 |
1985年 | 123篇 |
1984年 | 101篇 |
1983年 | 76篇 |
1982年 | 57篇 |
1981年 | 55篇 |
1980年 | 45篇 |
1979年 | 63篇 |
1978年 | 57篇 |
1977年 | 49篇 |
1976年 | 61篇 |
1975年 | 56篇 |
1974年 | 59篇 |
1973年 | 47篇 |
1972年 | 41篇 |
1966年 | 40篇 |
排序方式: 共有6831条查询结果,搜索用时 15 毫秒
1.
S. M. White C. L. Shelton A. W. Gelb C. Lawson F. McGain J. Muret J. D. Sherman representing the World Federation of Societies of Anaesthesiologists Global Working Group on Environmental Sustainability in Anaesthesia 《Anaesthesia》2022,77(2):201-212
The Earth’s mean surface temperature is already approximately 1.1°C higher than pre-industrial levels. Exceeding a mean 1.5°C rise by 2050 will make global adaptation to the consequences of climate change less possible. To protect public health, anaesthesia providers need to reduce the contribution their practice makes to global warming. We convened a Working Group of 45 anaesthesia providers with a recognised interest in sustainability, and used a three-stage modified Delphi consensus process to agree on principles of environmentally sustainable anaesthesia that are achievable worldwide. The Working Group agreed on the following three important underlying statements: patient safety should not be compromised by sustainable anaesthetic practices; high-, middle- and low-income countries should support each other appropriately in delivering sustainable healthcare (including anaesthesia); and healthcare systems should be mandated to reduce their contribution to global warming. We set out seven fundamental principles to guide anaesthesia providers in the move to environmentally sustainable practice, including: choice of medications and equipment; minimising waste and overuse of resources; and addressing environmental sustainability in anaesthetists’ education, research, quality improvement and local healthcare leadership activities. These changes are achievable with minimal material resource and financial investment, and should undergo re-evaluation and updates as better evidence is published. This paper discusses each principle individually, and directs readers towards further important references. 相似文献
2.
3.
4.
Patrick Hayes H. Sherman Jonathan H. Elder J. Bradley Olson Jeffrey J. 《Journal of neuro-oncology》2022,158(2):167-177
Journal of Neuro-Oncology - In patients with previously diagnosed glioblastoma who are suspected of experiencing progression, does repeat cytoreductive surgery improve progression free survival or... 相似文献
5.
6.
7.
Ann Dao Madison Cuffy Tiffany E. Kaiser Ashley Loethen John Cafardi Keith Luckett Adele Helen Rike Michael Cardi Rita R. Alloway Amit Govil Tayyab Diwan Kenneth E. Sherman Shimul A. Shah Ervin Steve Woodle 《Clinical transplantation》2019,33(7)
Hepatitis C (HCV) disease transmission from the use of HCV antibody‐positive and HCV nucleic acid test‐negative (HCV Ab+/NAT?) kidneys have been anecdotally reported to be absent. We prospectively analyzed kidney transplant (KT) outcomes from HCV Ab+/NAT? donors to HCV naïve recipients under T‐cell depleting early steroid withdrawal immunosuppression. Allografts from 40 HCV Ab+/NAT? donors were transplanted to 52 HCV Ab? recipients between July 2016 and February 2018. Thirty‐three (82.5%) of donors met Public Health Service (PHS) increased risk criteria. De novo HCV infection was detected at 3 months post‐KT in one recipient (1.9%). This was a case of transmission from a HCV Ab+ NAT+ donor with an initial false‐negative NAT completed using sample collected on donor hospital admission (day 2). At the time of HCV diagnosis, a stored donor sample collected during procurement (day 4) was tested and resulted NAT‐positive. Subsequently, sustained virologic response (SVR) was achieved with 12 weeks of glecaprevir/pibrentasvir. One death with functioning graft at 261 days post‐KT was determined not related to HCV or donor factors. This experience provides evidence of a low transmission rate of HCV from HCV Ab+/ NAT? kidney donors, thereby arguing for increasing utilization. 相似文献
8.
9.
Robert K. Nam MD Tania Benatar PhD Christopher J. D. Wallis MD Elizabeth Kobylecky MSc Yutaka Amemiya PhD Christopher Sherman Arun Seth PhD 《The Prostate》2019,79(12):1435-1451
Background: We previously identified a panel of five microRNAs (miRNAs) associated with biochemical recurrence and metastasis following prostatectomy from prostate cancer patients using next-generation sequencing-based whole miRNome sequencing and quantitative polymerase chain reaction-based validation analysis. In this study, we examined the mechanism of action of miR-139-5p, one of the downregulated miRNAs identified in the panel. Methods: Using a cohort of 585 patients treated with radical prostatectomy, we examined the prognostic significance of miR-139 (dichotomized around the median) using the Kaplan-Meier method and Cox proportional hazard models. We validated these results using The Cancer Genome Atlas (TCGA) data. We created cell lines that overexpressed miR-139 to confirm its targets as well as examine pathways through which miR-139 may function using cell-based assays. Results: Low miR-139 expression was significantly associated with a variety of prognostic factors in prostate cancer, including Gleason score, pathologic stage, margin positivity, and lymph node status. MiR-139 expression was associated with prognosis: the cumulative incidence of biochemical recurrence and metastasis were significantly lower among patients with high miR-139 expression (P = .0004 and .038, respectively). Validation in the TCGA data set showed a significant association between dichotomized miR-139 expression and biochemical recurrence (odds ratio, 0.52; 95% confidence interval, 0.33-0.82). Overexpression of miR-139 in prostate cancer cells led to a significant reduction in cell proliferation and migration compared with control cells, with cells arrested in G2 of cell cycle. IGF1R and AXL were identified as potential targets of miR-139 based on multiple miRNA-binding sites in 3′-untranslated regions of both the genes and their association with prostate cancer growth pathways. Luciferase assays verified AXL and IGF1R as direct targets of miR-139. Furthermore, immunoblotting of prostate cancer cells demonstrated IGF1R and AXL protein expression were inhibited by miR-139 treatment, which was reversed by the addition of miR-139 antagomir. Examination of the molecular mechanism of growth inhibition by miR-139 revealed the downregulation of activated AKT and cyclin D1, with upregulation of the CDK inhibitor p21. Conclusions: miR-139 is associated with improved prognosis in patients with localized prostate cancer, which may be mediated through downregulation of IGF1R and/or AXL and associated signaling pathway components. 相似文献